Prototype preview – to be shaped in the Florence workshop
Combination treatments and treatment stacking
Demand for combination treatments is driving market growth – the global combination therapy in aesthetics market is forecast to reach $8.03 billion by the end of 2034.
Weight-loss medications
With weight-loss injections a huge part of the conversation, clinics are developing complementary treatments for skin laxity and facial ageing caused by rapid weight loss. The global obesity-drug market is expected to reach $105 billion by 2030.
The rise of regenerative aesthetics
Polynucleotides, bio-stimulating fillers and exosomes have surged in popularity, driving natural, long-term rejuvenation by stimulating the body's natural healing and helping bank valuable collagen.
'Less is more' – the end of overfilled faces
Patients are moving away from the overfilled look towards subtle, natural tweakments. The move to regenerative aesthetics and bio-stimulating injectables reflects this shift.
Menopause-informed approach
Up to 30% collagen loss in the first five years post menopause is driving high demand for rejuvenating procedures among women aged 40–69. Providers are shifting from symptom management to regenerative therapies that address dryness, thinning, laxity and pigmentation.
Longevity – 'skin span'
Longevity is moving beyond quality of life to longevity of skin health, as a holistic theme in aesthetics.